XENE FY 2014 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

XENEXenon Pharmaceuticals Inc.

$5B

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$28M+3.7% YoY

Gross Profit

$22M79.2% margin

Operating Income

$11M39.1% margin

Net Income

$13M45.9% margin

EPS (Diluted)

$0.94

Cash Flow

Operating Cash Flow

$266,000

Free Cash Flow

-$1M

Stock-Based Comp.

$760,000

Balance Sheet

Total Assets

$87M

Total Liabilities

$15M

Stockholders' Equity

$73M

Cash & Equivalents

$72M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$28M	$27M	+3.7%
Gross Profit	$22M	$21M	+6.2%
Operating Income	$11M	$10M	+14.4%
Net Income	$13M	$12M	+8.2%